title: BaselinTc99-MIBI scanning predicts survival in multiple myeloma and helps to differentiate this disease from monoclonal gammopathy of unknown significance.
abstract: We performed baselineTc(99)-MIBI scanning in 43 patients with multiple myeloma (MM) and in 31 with monoclonal gammopathy of unknown significance (MGUS) patients. We identified two groups of MM patients whose actuarial survival correlated with low or high MIBI scores. MGUS patients had normal or very low scores.
authors.forename: Martín Gutiérrez
authors.initials: MG
authors.lastname: Martín
authors.forename: María Soledad
authors.initials: MS
authors.lastname: Romero Colás
authors.forename: María Victoria
authors.initials: MV
authors.lastname: Dourdil Sahún
authors.forename: Pilar
authors.initials: P
authors.lastname: Olave
authors.forename: Paula Razola
authors.initials: PR
authors.lastname: Alba
authors.forename: Javier Banzo Narraco
authors.initials: JB
authors.lastname: Banzo
mesh_terms: D003937:Diagnosis, Differential; D006801:Humans; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000401:mortality; D010265:Paraproteinemias / Q000000981:diagnostic imaging*; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D016019:Survival Analysis; D017256:Technetium Tc 99m Sestamibi
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi